<?xml version="1.0" encoding="UTF-8"?>
<ref id="B1-pharmaceutics-12-00138">
 <label>1.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bonferoni</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Ferraro</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Pavan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Beggiato</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Cavalieri</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Giunchedi</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Dalpiaz</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Uptake in the central nervous system of geraniol oil encapsulated in chitosan oleate following nasal and oral administration</article-title>
  <source>Pharmaceutics</source>
  <year>2019</year>
  <volume>11</volume>
  <elocation-id>106</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics11030106</pub-id>
  <?supplied-pmid 30832389?>
  <pub-id pub-id-type="pmid">30832389</pub-id>
 </element-citation>
</ref>
